Ali McbrideBS, MS, PharmD, BCPS, BCOP, FAzPA
Ali McBride is the Clinical Coordinator of Hematology/Oncology at The University of Arizona Cancer Center. He currently serves as Secretary of the Association of Community Cancer Centers (ACCC) and he has been actively involved with the American Society of Health-System Pharmacy (ASHP) currently serving as the Chair for the SAG on Emerging Sciences.
Dr. McBride has been working on oncology drug shortages and has testified on behalf of HOPA at FDA Drug Shortage Workshop, presented on behalf of ACCC at the Washington DC Congressional Session and was an invited member of the ASHP Drug Shortage Stakeholders Meeting. Dr. McBride is also actively involved with Biosimilar regulation and the pharmacoecomic impact of biosimilars into the US Marketplace.
He currently serves as a working group member for HOPA on its biosimilar committee. In addition, he currently serves on the National Quality Forum Cancer Standing Committee. He has published numerous articles focussing on drug shortages, oral chemotherapy adherence, stem cell transplant and biosimilar implementation into the US health care market.